These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1360 related items for PubMed ID: 28623754

  • 1. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M, Zarabla A, Maialetti A, Fabi A, Vidiri A, Villani V, Giannarelli D.
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [Abstract] [Full Text] [Related]

  • 2. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C, Placidi F, Liguori C, Mari L, Ulivi M, Ornello R, Pisani A, Mercuri NB, Izzi F.
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [Abstract] [Full Text] [Related]

  • 3. Lacosamide on background eeg activity in brain tumor-related epilepsy patients: A case series study.
    Maschio M, Zarabla A, Maialetti A, Sperati F, Dinapoli L, Dispenza S, Petreri G, Cantelmi T.
    Brain Behav; 2018 Nov; 8(11):e01067. PubMed ID: 30334378
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.
    Maschio M, Dinapoli L, Mingoia M, Sperati F, Pace A, Pompili A, Carapella CM, Vidiri A, Muti P.
    J Neurol; 2011 Nov; 258(11):2100-4. PubMed ID: 21674196
    [Abstract] [Full Text] [Related]

  • 10. Lacosamide and sodium channel-blocking antiepileptic drug cross-titration against levetiracetam background therapy.
    Baulac M, Byrnes W, Williams P, Borghs S, Webster E, De Backer M, Dedeken P.
    Acta Neurol Scand; 2017 Apr; 135(4):434-441. PubMed ID: 27714769
    [Abstract] [Full Text] [Related]

  • 11. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME, Fertig EJ, Trobliger RW, Perrine K, Myers L, Iyengar SS, Malik M.
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [Abstract] [Full Text] [Related]

  • 12. Adjunctive lacosamide in clinical practice: sodium blockade with a difference?
    Stephen LJ, Kelly K, Parker P, Brodie MJ.
    Epilepsy Behav; 2011 Nov; 22(3):499-504. PubMed ID: 21890421
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of lacosamide in infants and young children with refractory focal epilepsy.
    Grosso S, Parisi P, Spalice A, Verrotti A, Balestri P.
    Eur J Paediatr Neurol; 2014 Jan; 18(1):55-9. PubMed ID: 24129195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.
    Maschio M, Dinapoli L, Sperati F, Pace A, Fabi A, Vidiri A, Pompili A, Carapella CM.
    Epileptic Disord; 2012 Dec; 14(4):388-97. PubMed ID: 23248037
    [Abstract] [Full Text] [Related]

  • 16. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R, Ley M, Molins A, Toledo M, Sansa G, Bertol V, Becerra JL, Carreño M, Mauri JÁ.
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A, D'Souza W, Hepworth G, Lawn N, Cook M, Nikpour A.
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [Abstract] [Full Text] [Related]

  • 18. A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures.
    Steinhoff BJ, Eckhardt K, Doty P, De Backer M, Brunnert M, Schulze-Bonhage A.
    Epilepsy Behav; 2016 May; 58():35-43. PubMed ID: 27054272
    [Abstract] [Full Text] [Related]

  • 19. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B, Hemdal P, Privitera MD.
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.